Downstream processing of viral vectors and vaccines (Q36288881)

13 August 2017

1 reference

title

Downstream processing of viral vectors and vaccines (English)

1 reference

13 August 2017

Morenweiser R

1

1 reference

PubMed ID

16231042

13 August 2017

language of work or name

1 reference

1 October 2005

1 reference

13 August 2017

1 reference

13 August 2017

12 Suppl 1

1 reference

13 August 2017

S103-10

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302624

13 August 2017

0 references

cites work

T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Biochemical recovery and purification of gene therapy vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Production of viral vectors for gene therapy applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Downstream processing of plasmid DNA for gene therapy and DNA vaccine applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

A simple method for obtaining highly viable virus from culture supernatant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Rapid purification of extracellular and intracellular Moloney murine leukemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Large-scale processing of recombinant retroviruses for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Extraction of HIV-1 in aqueous two-phase systems to obtain a high yield of gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Direct visualisation of plasmid DNA in individual chromatography adsorbent particles by confocal scanning laser microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Ionic strength- and temperature-induced K(Ca) shifts in the uncoating reaction of rotavirus strains RF and SA11: correlation with membrane permeabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Densonucleosis virus purification by ion exchange membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Hepatitis B surface antigen immunopurification using a plant-derived specific antibody produced in large scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Novel tools for production and purification of recombinant adenoassociated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Viral vectors for gene transfer: a review of their use in the treatment of human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Kinetic analyses of stability of simple and complex retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Low-speed centrifugation of retroviral vectors absorbed to a particulate substrate: a highly effective means of enhancing retroviral titre.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Purification of a functional gene therapy vector derived from Moloney murine leukaemia virus using membrane filtration and ceramic hydroxyapatite chromatography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

A highly efficient and consistent method for harvesting large volumes of high-titre lentiviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Production and concentration of pseudotyped HIV-1-based gene transfer vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Characterization of highly purified, inactivated HIV-1 particles isolated by anion exchange chromatography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

A new scalable method for the purification of recombinant adenovirus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Development and optimization of an adenovirus production process

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Viral vectors in gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

An improved anion-exchange HPLC method for the detection and purification of adenoviral particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Serum-free production and column purification of adeno-associated virus type 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Scaleable chromatographic purification process for recombinant adeno-associated virus (rAAV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Viral receptors and vector purification: new approaches for generating clinical-grade reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

A single-step affinity column for purification of serotype-5 based adeno-associated viral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Improving rAAV production and purification: towards the definition of a scaleable process

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Targeting gene expression selectively in cancer cells by using the progression-elevated gene-3 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302624

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302624

1 reference

PubMed ID

16231042

Dimensions Publication ID

13 August 2017

0 references

1 reference

PubMed ID

16231042